Advertisement
UK markets closed
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • CRUDE OIL

    82.75
    +0.06 (+0.07%)
     
  • GOLD FUTURES

    2,396.00
    +7.60 (+0.32%)
     
  • DOW

    37,710.54
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    50,501.41
    +1,017.91 (+2.06%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    15,595.50
    -87.87 (-0.56%)
     
  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     

3 Surprisingly Underrated Stocks to Buy in April

3 Surprisingly Underrated Stocks to Buy in April

Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out. Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use. The company's stock is down by 19% since the start of the year.